EAPB0202

EAPB0202 is an imidazolium and quinoxaline derivative. EAPB0202 shows significant cytotoxicity to A375 human melanoma cell line with an IC50 of 2.35 μM. EAPB0202 can be used in the study of cancer[1].

Product Specifications

CAS Number

[681284-82-2]

UNSPSC

12352005

Target

Drug Derivative

Related Pathways

Others

Field of Research

Cancer

Smiles

NC1=NC2=C(N3C(CCC4=CC=CC=C4)=CN=C31)C=CC=C2

Molecular Formula

C18H16N4

Molecular Weight

288.35

References & Citations

[1]Moarbess G, et al. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives. Bioorg Med Chem. 2008 Jul 1;16 (13) :6601-10.